Science Ventures Denmark A/S

Science Ventures is a partner in the new international diabetes start-up.

Publiceret d. 04-11-2015
Science Ventures Denmark co-founded the newly formed biotech company Caldan Therapeutics Ltd by assigning patents and research from University of Southern Denmark.

Caldan has just closed an "A-Round" investment of more than GBP 4,45 mio. and is now ready to take the first step towards the further development of research results from the University of Southern Denmark and Glasgow University to new drugs against diabetes.
Investors in Caldan Therapeutics is besides Science Ventures international venture fund Epidarex, backed by Eli Lilly company, Scottish Investment Bank and Glasgow University.
Caldan founded in Glasgow.

Link to the press release.


Science Ventures Denmark A/S

Cortex Park 26
DK-5230 Odense M
Mobile: +45 31 787 780